5,753
Views
15
CrossRef citations to date
0
Altmetric
Oncology

Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer

ORCID Icon, ORCID Icon, ORCID Icon, , , & show all
Pages 457-468 | Received 10 Feb 2022, Accepted 11 Mar 2022, Published online: 30 Mar 2022